| 1 |
Danilova NV, Chayka AV, Khomyakov VM, Oleynikova NA, Andreeva YY, Malkov PG, Sotnikova TN. [Mucins expression in gastric cancer: connection of MUC status with clinical, morphological and prognostic characteristics of the tumor]. Arkh Patol 2023;85:16-28. [PMID: 36785958 DOI: 10.17116/patol20238501116] [Reference Citation Analysis]
|
| 2 |
Gómez-Gallegos AA, Ramírez-Vidal L, Becerril-Rico J, Pérez-Islas E, Hernandez-Peralta ZJ, Toledo-Guzmán ME, García-Carrancá A, Langley E, Hernández-Guerrero A, López-Casillas F, Herrera-Goepfert R, Oñate-Ocaña LF, Ortiz-Sánchez E. CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence. Stem Cell Res Ther 2023;14:16. [PMID: 36737794 DOI: 10.1186/s13287-023-03241-7] [Reference Citation Analysis]
|
| 3 |
Chen JJ, Jin JM, Gu WJ, Zhao Z, Yuan H, Zhou YD, Nagle DG, Xi QL, Zhang XM, Sun QY, Wu Y, Zhang WD, Luan X. Crizotinib-based proteolysis targeting chimera suppresses gastric cancer by promoting MET degradation. Cancer Sci 2023. [PMID: 36692137 DOI: 10.1111/cas.15733] [Reference Citation Analysis]
|
| 4 |
Liu Z, Hong LL, Zheng JS, Ling ZN, Zhang ZL, Qi YN, Zhang XY, Zhu TY, Wang JL, Han J, Chen XL, Yu QM, Wang S, Li P, Ling ZQ. Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica. Gastric Cancer 2023;26:203-19. [PMID: 36450891 DOI: 10.1007/s10120-022-01353-2] [Reference Citation Analysis]
|
| 5 |
Sun G, Fu G, Tang Y, Yi J, Su R, Liu W, Lu X, Li X. A novel frameshift mutation of the ATM gene in a Chinese family with hereditary gastrointestinal tumors. All Life 2022;15:718-27. [DOI: 10.1080/26895293.2022.2087105] [Reference Citation Analysis]
|
| 6 |
Wang G, Zhou X, Li Y, Zhao M, Zou Y, Lu Q, Wu Y, Zhong WL. Comprehensive Multiomics Analysis Identified IQGAP3 as a Potential Prognostic Marker in Pan-Cancer. Disease Markers 2022;2022:1-33. [DOI: 10.1155/2022/4822964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Yu Z, Lan J, Li W, Jin L, Qi F, Yu C, Zhu H, Li T. Circular RNA hsa_circ_0002360 Promotes Proliferation and Invasion and Inhibits Oxidative Stress in Gastric Cancer by Sponging miR-629-3p and Regulating the PDLIM4 Expression. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/2775433] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Yu H, Luo S. Low Expression of miR-491-3p Is Correlated with Lymph Node Metastasis in Gastric Cancer. Evid Based Complement Alternat Med 2022;2022:7807956. [PMID: 35815280 DOI: 10.1155/2022/7807956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Kong F, Yan Z, Lan N, Wang P, Fan S, Yuan W. Construction and validation of gastric cancer diagnosis model based on machine learning. Exploration of Medicine 2022. [DOI: 10.37349/emed.2022.00094] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Liu B, Chen L, Huang H, Huang H, Jin H, Fu C. Prognostic and Immunological Value of GNB4 in Gastric Cancer by Analyzing TCGA Database. Dis Markers 2022;2022:7803642. [PMID: 35756485 DOI: 10.1155/2022/7803642] [Reference Citation Analysis]
|
| 11 |
Ooki A, Yamaguchi K. The dawn of precision medicine in diffuse-type gastric cancer. Ther Adv Med Oncol 2022;14:175883592210830. [DOI: 10.1177/17588359221083049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Cheng M, Zhan X, Xu Y, Wang S, Zhang H, Fang L, Jin H, Chen W. DNA methylation of RNA-binding protein for multiple splicing 2 functions as diagnosis biomarker in gastric cancer pathogenesis and its potential clinical significance. Bioengineered 2022;13:4347-60. [PMID: 35137653 DOI: 10.1080/21655979.2022.2032965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Xu B, Chu Y, Hu Q, Song Q. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma. Technol Cancer Res Treat 2021;20:15330338211055340. [PMID: 34806493 DOI: 10.1177/15330338211055340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 14 |
Deng S, Li L, Xu S, Wang X, Han T. Promotion of gastric tumor initiating cells in a 3D collagen gel culture model via YBX1/SPP1/NF-κB signaling. Cancer Cell Int 2021;21:599. [PMID: 34758833 DOI: 10.1186/s12935-021-02307-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 15 |
Ruiz Hispán E, Pedregal M, Cristobal I, García-Foncillas J, Caramés C. Immunotherapy for Peritoneal Metastases from Gastric Cancer: Rationale, Current Practice and Ongoing Trials. J Clin Med 2021;10:4649. [PMID: 34682772 DOI: 10.3390/jcm10204649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Shi X, Ding K, Zhao Q, Li P, Kang Y, Tan S, Sun J. Suppression of CPSF6 Enhances Apoptosis Through Alternative Polyadenylation-Mediated Shortening of the VHL 3'UTR in Gastric Cancer Cells. Front Genet 2021;12:707644. [PMID: 34594359 DOI: 10.3389/fgene.2021.707644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Yu X, Cao F, Yu Y, Li Y, Zhang J, Xu T, Di Q, Wu G, Zhang Z, Wang R, Li Y. HNRNPL Is Identified and Validated as a Prognostic Biomarker Associated with Microsatellite Instability in Human Gastric Cancer. DNA Cell Biol 2021;40:1251-60. [PMID: 34491823 DOI: 10.1089/dna.2021.0165] [Reference Citation Analysis]
|
| 18 |
Jiangzhou H, Zhang H, Sun R, Fahira A, Wang K, Li Z, Shi Y, Wang Z. Integrative omics analysis reveals effective stratification and potential prognosis markers of pan-gastrointestinal cancers. iScience 2021;24:102824. [PMID: 34381964 DOI: 10.1016/j.isci.2021.102824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 19 |
Wang J, Shao X, Liu Y, Shi R, Yang B, Xiao J, Liu Y, Qu X, Li Z. Mutations of key driver genes in gastric cancer metastasis risk: a systematic review and meta-analysis. Expert Rev Mol Diagn 2021;:1-10. [PMID: 34196586 DOI: 10.1080/14737159.2021.1946394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Kim KW, Kim N, Choi Y, Kim WS, Yoon H, Shin CM, Park YS, Lee DH, Park YS, Ahn SH, Park DJ, Kim HH, Lee HS, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH. Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study. Gastric Cancer 2021;24:844-57. [PMID: 33598811 DOI: 10.1007/s10120-021-01163-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 21 |
Jonaitis P, Kupcinskas L, Kupcinskas J. Molecular Alterations in Gastric Intestinal Metaplasia. Int J Mol Sci 2021;22:5758. [PMID: 34071181 DOI: 10.3390/ijms22115758] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 22 |
Yang M, Arai E, Takahashi Y, Totsuka H, Chiku S, Taniguchi H, Katai H, Sakamoto H, Yoshida T, Kanai Y. Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas: significance of cell adhesion and epithelial-mesenchymal transition-related signaling pathways. Carcinogenesis 2020;41:1473-84. [PMID: 32710740 DOI: 10.1093/carcin/bgaa079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 23 |
Gingold-Belfer R, Kessler-Icekson G, Morgenstern S, Rath-Wolfson L, Zemel R, Boltin D, Levi Z, Herman-Edelstein M. The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves POPDC1 and POPDC3 Downregulation. Int J Mol Sci 2021;22:5359. [PMID: 34069715 DOI: 10.3390/ijms22105359] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 24 |
Ji Y, Gao L, Zhang C, Sun X, Dai L, Ji Z, Zhang J, Zhang Z, Cao W, Zhao Y, Zhang L. Identification of the hub genes and prognostic indicators of gastric cancer and correlation of indicators with tumor-infiltrating immune cell levels. J Cancer 2021;12:4025-38. [PMID: 34093807 DOI: 10.7150/jca.52105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 25 |
Dong N, Guo R, Gong Y, Yuan Y. Phenotype characteristics of gastric epithelial mucus in patients with different gastric diseases: from superficial gastritis to gastric cancer. PeerJ 2021;9:e10822. [PMID: 33665018 DOI: 10.7717/peerj.10822] [Reference Citation Analysis]
|
| 26 |
Díaz Del Arco C, Ortega Medina L, Estrada Muñoz L, García Gómez de Las Heras S, Fernández Aceñero MJ. Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis. Histol Histopathol 2021;36:587-613. [PMID: 33565601 DOI: 10.14670/HH-18-309] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
|
| 27 |
Sun W, Jiang C, Ji Y, Xiao C, Song H. Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer. Biomed Res Int 2021;2021:8853269. [PMID: 33506041 DOI: 10.1155/2021/8853269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Yasufuku I, Saigo C, Kito Y, Yoshida K, Takeuchi T. Prognostic significance of LDL receptor-related protein 1B in patients with gastric cancer. J Mol Histol 2021;52:165-72. [PMID: 33389427 DOI: 10.1007/s10735-020-09932-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 29 |
Mallath MK. Gastric Cancer. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_77] [Reference Citation Analysis]
|
| 30 |
Mallath MK. Gastric Cancer. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-319-90761-1_77-1] [Reference Citation Analysis]
|
| 31 |
Ishikawa A, Kuraoka K, Zaitsu J, Saito A, Kuwai T, Suzuki T, Tashiro H, Taniyama K, Yasui W. Loss of Annexin A10 Expression Is Associated with Poor Prognosis in Early Gastric Cancer. Acta Histochem Cytochem 2020;53:113-9. [PMID: 33177783 DOI: 10.1267/ahc.20-00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Yao X, Ajani JA, Song S. Molecular biology and immunology of gastric cancer peritoneal metastasis. Transl Gastroenterol Hepatol 2020;5:57. [PMID: 33073052 DOI: 10.21037/tgh.2020.02.08] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 33 |
Alzeeb G, Metges JP, Corcos L, Le Jossic-Corcos C. Three-Dimensional Culture Systems in Gastric Cancer Research. Cancers (Basel) 2020;12:E2800. [PMID: 33003476 DOI: 10.3390/cancers12102800] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 34 |
Ning L, Wang L, Zhang H, Jiao X, Chen D. Eukaryotic translation initiation factor 5A in the pathogenesis of cancers. Oncol Lett 2020;20:81. [PMID: 32863914 DOI: 10.3892/ol.2020.11942] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 35 |
Bian SB, Yang Y, Liang WQ, Zhang KC, Chen L, Zhang ZT. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway. Ann N Y Acad Sci 2021;1484:74-89. [PMID: 32827446 DOI: 10.1111/nyas.14466] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 36 |
Cao F, Zheng Y, Yang C, Huang S, He X, Tong S. miR-635 targets KIFC1 to inhibit the progression of gastric cancer. J Investig Med 2020;68:1357-63. [DOI: 10.1136/jim-2020-001438] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 37 |
Dos Santos Pereira E, Magalhães Albuquerque L, de Queiroz Balbino V, da Silva Junior WJ, Rodriguez Burbano RM, Pordeus Gomes JP, Barem Rabenhorst SH. Helicobacter pylori cagE, cagG, and cagM can be a prognostic marker for intestinal and diffuse gastric cancer. Infect Genet Evol 2020;84:104477. [PMID: 32736040 DOI: 10.1016/j.meegid.2020.104477] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 38 |
Accordino G, Lettieri S, Bortolotto C, Benvenuti S, Gallotti A, Gattoni E, Agustoni F, Pozzi E, Rinaldi P, Primiceri C, Morbini P, Lancia A, Stella GM. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. Cancers (Basel) 2020;12:E2105. [PMID: 32751137 DOI: 10.3390/cancers12082105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
Koustas E, Karamouzis MV, Sarantis P, Schizas D, Papavassiliou AG. Inhibition of c-MET increases the antitumour activity of PARP inhibitors in gastric cancer models. J Cell Mol Med 2020;24:10420-31. [PMID: 32686903 DOI: 10.1111/jcmm.15655] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 40 |
Assumpção PP, Barra WF, Ishak G, Coelho LGV, Coimbra FJF, Freitas HC, Dias-Neto E, Camargo MC, Szklo M. The diffuse-type gastric cancer epidemiology enigma. BMC Gastroenterol 2020;20:223. [PMID: 32660428 DOI: 10.1186/s12876-020-01354-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
